Results 21 to 30 of about 16,074 (250)

Naproxen sodium decreases migraine recurrence when administered with sumatriptan [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2000
Forty to 78% of the patients using sumatriptan for the acute treatment of migraine may present recurrence at least occasionally. The concomitant use of a NSAID (nonsteroidal anti-inflammatory drug) has been recommended to decrease the recurrence rate ...
ABOUCH VALENTY KRYMCHANTOWSKI
doaj   +1 more source

Sumatriptan

open access: yesReactions Weekly, 1994
europepmc   +3 more sources

Triptans and CGRP blockade - impact on the cranial vasculature [PDF]

open access: yes, 2017
The trigeminovascular system plays a key role in the pathophysiology of migraine. The activation of the trigeminovascular system causes release of various neurotransmitters and neuropeptides, including serotonin and calcitonin gene-related peptide ...
Alejandro Labastida-Ramírez   +9 more
core   +3 more sources

Anti-Inflammatory and Antioxidative Effects of Sumatriptan Against Doxorubicin-Induced Cardiotoxicity in Rat

open access: yesActa Medica Iranica, 2021
The clinical use of doxorubicin as a potent chemotherapeutic agent is limited due to its dose-dependent cardiotoxicity. Oxidative stress and inflammatory pathways have a pivotal role in the doxorubicin-induced cardiotoxicity.
Mohammad Sheibani   +7 more
doaj   +1 more source

Up to date on the use of triptans for child and adolescent migraine: “the state of the art” [PDF]

open access: yes, 2001
The introduction of triptans, in the early 1990s, has improved the therapy for acute migraine attack, offering a new quality of life for those patients who suffer from this disabling neurological disorder. Epidemiological data point out that about 10% of
D. CALDERONI   +2 more
core   +1 more source

Sumatriptan activates TRPA1

open access: yesCephalalgia Reports, 2019
Background: Migraine therapy with sumatriptan may cause adverse side effects like pain at the injection site, muscle pain, and transient aggravation of headaches.
Alexandru Babes   +3 more
doaj   +1 more source

Eletriptan in the management of acute migraine. An update on the evidence for efficacy, safety, and consistent response [PDF]

open access: yes, 2016
Migraine is a multifactorial, neurological and disabling disorder, also characterized by several autonomic symptoms. Triptans, selective serotonin 5-HT1B/1D agonists, are the first-line treatment option for moderate-to-severe headache attacks.
Capi, Matilde   +6 more
core   +1 more source

Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure [PDF]

open access: yes, 2017
Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood.
Hurley, Joyce Harts   +4 more
core   +1 more source

Sumatriptan as abortive treatment in cyclic vomiting syndrome: A cross-sectional study

open access: yesCephalalgia Reports, 2020
Cyclic vomiting syndrome (CVS) is characterized by episodic vomiting and shares similarities with migraine headache. Guidelines recommend using triptans as abortive therapy in CVS, but there are limited data on its efficacy.
Bixuan Lin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy